论文信息 - Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom - 字舞流文

Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom

J. Lechner-Scott | M. Trojano | F. Grand'Maison | E. Havrdová | H. Butzkueven | A. van der Walt | G. Izquierdo | A. Lugaresi | C. Boz | C. Oreja-Guevara | P. Duquette | P. Sola | F. Granella | R. Hupperts | T. Spelman | D. Horáková | T. Kalincik | P. Grammond | V. van Pesch | V. Jokubaitis | G. De Luca | E. Pucci | R. Hyde | D. Ferraro | M. Terzi | G. Izquierdo | U. Freudensprung | G. Luca | I. Pearson | M. Tempest | C. Rozsa | F. Grand’Maison | W. Herring | Yuanhui Zhang | Eugenio Pucci | C. Acosta | T. Dort | Maria Trojano | R. Alroughani | Csilla Rozsa | T E D M G A G P P R E F J P D F. M C C R V C A V. G. Spelman Havrdova Horakova Trojano Luca Lugaresi | M Trojano | E Pucci | C Rozsa | T. Spelman | D. Horáková | G. Izquierdo | G. Luca | E. Pucci | G. Luca | D. Horakova